0001950047-24-001409.txt : 20240226 0001950047-24-001409.hdr.sgml : 20240226 20240226163223 ACCESSION NUMBER: 0001950047-24-001409 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240226 DATE AS OF CHANGE: 20240226 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Vir Biotechnology, Inc. CENTRAL INDEX KEY: 0001706431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812730369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39083 FILM NUMBER: 24679448 BUSINESS ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-906-4324 MAIL ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: SCANGOS GEORGE A CENTRAL INDEX KEY: 0001202102 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY CITY: SAN FRANCISCO STATE: CA ZIP: 94083 144 1 primary_doc.xml 144 0001202102 XXXXXXXX LIVE 0001706431 VIR BIOTECHNOLOGY INC 001-39083 1800 Owens Street Suite 900 San Francisco CA 94158 4159064324 GEORGE SCANGOS Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

17722 204334.66 134521285 02/26/2024 NASDAQ Common 02/22/2024 Restricted Stock Units Issuer N 17722 02/22/2024 N/A N 10b5-1 Sales for GEORGE SCANGOSTOD LESLIE WILSONSUBJECT TO STA RULES

1800 Owens Street Suite 900 San Francisco CA 94158

Common 02/20/2024 16872 172384.60 02/26/2024 10/20/2023 /s/ George Scangos